Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Rebecca Thomas and Storm Newton

Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn

Mounjaro, an injectable medicine used to treat Type 2 diabetes. -

Fewer than 10 per cent of patients in England who are eligible for what has been dubbed the “King Kong of weight loss drugs” will initially be able to access it on the health service.

Health officials revealed on Thursday they are prioritising the drug for people with the highest needs.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.